Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer

Korean Journal of Internal Medicine

Volumn 28, Issue 5, 2013, Pages 525-537

  Choi, Il Ju ^a  

^a National Cancer Center   (South Korea)

Author keywords

Helicobacter pylori; Prevention and control; Stomach neoplasms

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; ANTIBIOTIC AGENT; ASCORBIC ACID; CAGA PROTEIN; GARLIC EXTRACT; GARLIC OIL; INTERLEUKIN 10; INTERLEUKIN 1BETA; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; SELENIUM; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT;

BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC SURGERY; ERADICATION THERAPY; FAMILY HISTORY; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; HEALTH INSURANCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; JAPAN; KOREA; MEDICAL RESEARCH; MULTICENTER STUDY (TOPIC); PRACTICE GUIDELINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REIMBURSEMENT; RETROSPECTIVE STUDY; REVIEW; STOMACH ATROPHY; STOMACH CANCER; TREATMENT INDICATION; COMPLICATION; DRUG COMBINATION; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; GASTRITIS; HELICOBACTER INFECTIONS; MICROBIOLOGY; RISK FACTOR; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; GASTRECTOMY; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PROTON PUMP INHIBITORS; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84883779773     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2013.28.5.525     Document Type: Review

References (81)

1. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607-615.
2. Nomura A, Stemmermann GN, Chyou PH, Kato I, Pe-rez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-1136.
3. Parsonnet J, Friedman GD, Vandersteen DP, et al. Heli-cobacter pylori infection and the risk of gastric carcino-ma. N Engl J Med 1991;325:1127-1131.
4. Schistosomes, liver f lukes and Helicobacter pylori: IARC Working Group on the Evaluation of Carcinogen-ic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
5. Sugiyama A, Maruta F, Ikeno T, et al. Helicobacter pylo-ri infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Can-cer Res 1998;58:2067-2069.
6. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Heli-cobacter pylori infection induces gastric cancer in mon-golian gerbils. Gastroenterology 1998;115:642-648.
7. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective co-horts. Gut 2001;49:347-353.
8. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
9. Kim SG, Jung HK, Lee HL, et al. Guidelines for the di-agnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol 2013;62:3-26.
10. Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori, Liu WZ, et al. Fourth Chinese National Consensus Report on the man- agement of Helicobacter pylori infection. J Dig Dis 2013;14:211-221.
11. Malfertheiner P, Megraud F, O'Morain CA, et al. Man-agement of Helicobacter pylori infection: the Maas-tricht IV/ Florence Consensus Report. Gut 2012;61:646-664.
12. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010;15:1-20.
13. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pa-cific Consensus Guidelines for Helicobacter pylori in-fection. J Gastroenterol Hepatol 2009;24:1587-1600.
14. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the manage-ment of Helicobacter pylori infection. Am J Gastroen-terol 2007;102:1808-1825.
15. Lee SY. Future candidates for indications of Helico-bacter pylori eradication: do the indications need to be revised? J Gastroenterol Hepatol 2012;27:200-211.
16. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-397.
17. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Mar-gantinis G. The long-term impact of Helicobacter pylo-ri eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007;12 Suppl 2:32-38.
18. Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut 2005;54:735-738.
19. Wong BC, Lam SK, Wong WM, et al. Helicobacter py-lori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-194.
20. Graham DY, Uemura N. Natural history of gastric can-cer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally. Helicobacter 2006;11:139-143.
21. You WC, Brown LM, Zhang L, et al. Randomized dou-ble-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-983.
22. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012;104:488-492.
23. Schmid CH, Whiting G, Cory D, Ross SD, Chalmers TC. Omeprazole plus antibiotics in the eradication of Heli-cobacter pylori infection: a meta-regression analysis of randomized, controlled trials. Am J Ther 1999;6:25-36.
24. Osborn JF, Cattaruzza MS, Ferri AM, et al. How long will it take to reduce gastric cancer incidence by erad-icating helicobacter pylori infection? Cancer Prev Res (Phila) 2013;6:695-700.
25. Kato M, Nishida T, Yamamoto K, et al. Scheduled en-doscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut 2012 Aug 21 [Epub]. 10.1136/gutjnl-2011-301647.
26. Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy 2005;37:990-993.
27. Uemura N, Mukai T, Okamoto S, et al. Effect of Helico-bacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-642.
28. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report. Al-iment Pharmacol Ther 2002;16:167-180.
29. Kato M, Asaka M. Recent development of gastric cancer prevention. Jpn J Clin Oncol 2012;42:987-994.
30. Choi J, Kim SG, Im JP, Kim JS, Jung HC. Helicobacter pylori eradication after endoscopic resection of gastric tumors. Gastroenterology 2012;142(5-1):S-489.
31. Maehata Y, Nakamura S, Fujisawa K, et al. Long-term effect of Helicobacter pylori eradication on the develop-ment of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012;75:39-46.
32. de Vries AC, van Grieken NC, Looman CW, et al. Gas-tric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945-952.
33. Han JS, Jang JS, Choi SR, et al. A study of metachronous cancer after endoscopic resection of early gastric cancer. Scand J Gastroenterol 2011;46:1099-1104.
34. Bae SE, Jung HY, Jung JH, et al. Effect of eradication of Helicobacter pylori on recurrence after endoscopic resection of gastric adenoma and early gastric cancer. Gastroenterology 2012;142(5-1):S-183.
35. Kim YI, Kook MC, Kwak HW, et al. The association be-tween Helicobacter pylori status and incidence of meta-chronous gastric cancer after endoscopic resection of early gastric cancer. Gastroenterology 2013;144(5-1):S-328-S-329.
36. O'Connor HJ, Dixon MF, Wyatt JI, et al. Effect of duo-denal ulcer surgery and enterogastric reflux on Campy-lobacter pyloridis. Lancet 1986;2:1178-1181.
37. Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon AT. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002;51:351-355.
38. Cho SJ, Choi IJ, Kook MC, et al. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after sub-total gastrectomy for gastric cancer. Aliment Pharmacol Ther 2013;38:477-489.
39. Naylor GM, Gotoda T, Dixon M, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006;55:1545-1552.
40. Abdullah M, Ohtsuka H, Rani AA, Sato T, Syam AF, Fujino MA. Helicobacter pylori infection and gastrop-athy: a comparison between Indonesian and Japanese patients. World J Gastroenterol 2009;15:4928-4931.
41. Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence. Helicobacter 2012;17:396-401.
42. Kim J, Cho YA, Choi IJ, et al. Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One 2012;7:e29643.
43. Shanks AM, El-Omar EM. Helicobacter pylori in-fection, host genetics and gastric cancer. J Dig Dis 2009;10:157-164.
44. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differ-ences between Helicobacter pylori strains. Intern Med 2008;47:1077-1083.
45. Nguyen LT, Uchida T, Murakami K, Fujioka T, Moriya-ma M. Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J Med Microbiol 2008;57(12):1445-1453.
46. Kim N, Park YS, Cho SI, et al. Prevalence and risk fac- tors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008;13:245-255.
47. de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol 2009;104:1342-1345.
48. Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer 2010;102:237-242.
49. Shin CM, Kim N, Lee HS, et al. Intrafamilial aggre-gation of gastric cancer: a comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility. Eur J Gastroenter-ol Hepatol 2011;23:411-417.
50. Rokkas T, Sechopoulos P, Pistiolas D, Margantinis G, Koukoulis G. Helicobacter pylori infection and gas-tric histology in first-degree relatives of gastric cancer patients: a meta-analysis. Eur J Gastroenterol Hepatol 2010;22:1128-1133.
51. Nam JH, Choi IJ, Cho SJ, et al. Helicobacter pylo-ri infection and histological changes in siblings of young gastric cancer patients. J Gastroenterol Hepatol 2011;26:1157-1163.
52. Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, et al. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012;35:1451-1459.
53. Mabe K, Takahashi M, Oizumi H, et al. Does Helico-bacter pylori eradication therapy for peptic ulcer pre-vent gastric cancer? World J Gastroenterol 2009;15:4290- 4297.
54. Yanaoka K, Oka M, Ohata H, et al. Eradication of Heli-cobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsino-gen levels. Int J Cancer 2009;125:2697-2703.
55. Ogura K, Hirata Y, Yanai A, et al. The effect of Helico-bacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol 2008;42:279-283.
56. Takenaka R, Okada H, Kato J, et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, es-pecially of the intestinal type. Aliment Pharmacol Ther 2007;25:805-812.
57. Take S, Mizuno M, Ishiki K, et al. Baseline gastric mu-cosal atrophy is a risk factor associated with the devel-opment of gastric cancer after Helicobacter pylori erad-ication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007;42 Suppl 17:21-27.
58. Kato M, Asaka M. Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and re-cent progress of gastroendoscopic diagnosis and treat-ment for gastric cancer. Jpn J Clin Oncol 2010;40:828-837.
59. Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ul-cer disease. N Engl J Med 1996;335:242-249.
60. Correa P, Fontham ET, Bravo JC, et al. Chemopreven-tion of gastric dysplasia: randomized trial of antioxi-dant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-1888.
61. Saito D, Boku N, Fujioka T, et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese Intervention Trial (JITHP-Study). a randomized multi-center trial [abstract]. Gastroenter-ology 2005;128(4-2):A4.
62. Zhou L. Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in china. Gastroen-terology 2008;134(4-1):A-233.
63. Meimarakis G, Winter H, Assmann I, et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 2006;7:211-222.
64. Marrelli D, Pedrazzani C, Berardi A, et al. Negative He-licobacter pylori status is associated with poor progno-sis in patients with gastric cancer. Cancer 2009;115:2071-2080.
65. Hur H, Lee SR, Xuan Y, et al. The Effects of Helico-bacter pylori on the prognosis of patients with curative-ly resected gastric cancers in a population with high infection rate. J Korean Surg Soc 2012;83:203-211.
66. Wang F, Sun G, Zou Y, Zhong F, Ma T, Li X. Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer. PLoS One 2013;8:e62440.
67. Kwak HW, Choi IJ, Cho SJ, et al. Clinicopathological characteristics of gastric cancer according to the Heli-cobacter pylori infection status in a region of high prev-alence of gastric cancer. Gastroenterology 2013;144(5-1):S-325.
68. Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-neg-ative gastric cancer in South Korea: incidence and clin-icopathologic characteristics. Helicobacter 2011;16:382-388.
69. Kato S, Matsukura N, Tsukada K, et al. Helicobacter py-lori infection-negative gastric cancer in Japanese hospi-tal patients: incidence and pathological characteristics. Cancer Sci 2007;98:790-794.
70. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-neg-ative gastric cancer among Japanese. Helicobacter 2011;16:415-419.
71. Malfertheiner P, Selgrad M. Helicobacter pylori infec-tion and current clinical areas of contention. Curr Opin Gastroenterol 2010;26:618-623.
72. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylo-ri eradication?: a meta-analysis. Am J Gastroenterol 2010;105:1007-1013.
73. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control 2011;22:375-387.
74. Blaser M. Antibiotic overuse: stop the killing of benefi-cial bacteria. Nature 2011;476:393-394.
75. Chen Y, Segers S, Blaser MJ. Association between Heli- cobacter pylori and mortality in the NHANES III study. Gut 2013;62:1262-1269.
76. Manickam P, Gunasekaran P, Sudhakar R, Veeranna V, Afonso L. Association of Helicobacter pylori seropositivity with all-cause mortality: fact or fiction? Gut 2013;62:1385-1386.
77. Asaka M, Kato M, Graham DY. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 2010;49:633-636.
78. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer 2013;132:1272-1276.
79. Lee KS, Oh DK, Han MA, et al. Gastric cancer screening in Korea: report on the national cancer screening pro-gram in 2008. Cancer Res Treat 2011;43:83-88.
80. Nam SY, Choi IJ, Park KW, et al. Effect of repeated en-doscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 2009;21:855-860.
81. Cho E, Kang MH, Choi KS, Suh M, Jun JK, Park EC. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Asian Pac J Cancer Prev 2013;14:2533-2540.